Viracta Therapeutics Inc. buy me8
Start price
30.11.20
/
50%
€6.65
Target price
30.11.21
€10.50
Performance (%)
-21.05%
End price
14.12.20
€5.25
Summary
This prediction ended on 14.12.20 with a price of €5.25. The prediction for Viracta Therapeutics Inc. disappointed with a performance of -21.05%. me8 has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Viracta Therapeutics Inc. | -24.057% | -24.057% | -40.370% | -87.494% |
| iShares Core DAX® | 1.051% | -1.833% | 12.822% | 15.392% |
| iShares Nasdaq 100 | -0.547% | -3.738% | 40.625% | 42.396% |
| iShares Nikkei 225® | -1.778% | -8.115% | 16.092% | 0.891% |
| iShares S&P 500 | 0.002% | -2.226% | 28.387% | 41.095% |
According to me8 what are the pros and cons of Viracta Therapeutics Inc. for the foreseeable future?
Pros
Innovative
Could be worthwhile Investment >10% per year
Good culture
Cons
No uniques
Comments by me8 for this prediction
In the thread Sunesis Pharmaceuticals diskutieren
In the thread Trading Sunesis Pharmaceuticals
Stopped prediction by me8 for Viracta Therapeutics Inc.
Viracta Therapeutics Inc.
Start price
Target price
Perf. (%)
€15.09
23.02.21
23.02.21
-
23.02.22
23.02.22
18.33%
24.02.21
24.02.21
Innovative
Could be worthwhile Investment >10% per year
Good culture
No uniques
